Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

TV Review: Great Ormond Street - Fix My Genes

27 July 2015

By Daniel Malynn

Appeared in BioNews 812

Great Ormond Street: Fix My Genes

BBC2, Tuesday 14 July 2015

'Great Ormond Street: Fix My Genes', BBC2, Tuesday 14 July 2015


This series follows the staff and families of children who are receiving treatment at Great Ormond Street Hospital, and the first episode focuses on their world-leading team dealing with congenital diseases.

We meet three families, all facing rare genetic immune diseases for which Great Ormond Street has been pioneering new treatments. The documentary witnesses the utter anguish the families go through and the heartbreaking decisions parents have to make. The documentary has a warning that it 'contains upsetting scenes' but this is an understatement; it is truly a harrowing series of stories.

Herb, aged five, suffers from a rare immune disease called NEMO, and is under the care of Professor Paul Veys. Herb has to have a bone-marrow transplant from his older brother Rufus, who is fortunately a match. However, the treatment comes with a ten percent chance of mortality. This is something Herb's mum finds difficult to read in a letter from the hospital. 'That is just a statistic. My son is not a statistic,' she says.

Herb has the treatment using Rufus's bone marrow. Previously, a happy and spirited child, Herb becomes moody and depressed and must be kept in isolation for several weeks. He gets very upset when he loses his hair as a result of the chemotherapy, which is used to wipe out his immune system before the transplant. Another consequence of this, which causes greater concern for his parents, is that Herb must be made sicker before he can be made better again. And, if the transplant fails, he will have no immune system, leaving him defenceless to infection.

When he develops a fever after the transplant, there is real worry that Herb has an infection, which would be extremely dangerous. However, it could also be a sign that the transfusion has worked. We, and his parents, must wait to find out which of these outcomes it is.

We also meet Keano, who is nine years' old and has congenital neutropenia. Doctors are struggling to find a bone-marrow donor for him because of his rare mixed-race background – his mother is of mixed Indian descent and his father of mixed African–Caribbean descent.

Keano has the option of a transplant from his mother, who is a mismatched donor and only 50 percent compatible. And, with the high odds of failure – at up to 30 percent – she faces a painful decision: for the chance to give Keano a future, she must run the risk of losing him now.

After agonising over what to do, Keano's mum decides to proceed with the transplant. However, when Keano's body rejects the transfusion, he is left dangerously ill.

Staff work to get another donor from the USA in a record time of two weeks. But Keano then develops a fungal infection that causes sores all over his body, and he is clearly in a lot of pain. Dr Kanchan Rao takes over his care, but she is doubtful that he can recover and says that it will be a miracle if he survives.

Finally, the show follows Teigan, 10, who suffers from SCID (Severe Combined Immunodeficiency). Seven years ago she was one of the first patients to undergo gene therapy, but the chemotherapy caused serious side effects so was halted. She has now been on weekly injections to increase her white-cell count, but these are painful and not a long-term solution. Her family and doctors have made the decision to try gene therapy again, which has not been given to a child of Teigan's age before, now that less aggressive chemotherapy is available.

While the documentary shows how hard it is for patients to go through these treatments, through Teigan we see a different side to the story: the disappointment when treatment cannot go ahead. Difficulties in getting enough stem cells from Teigan's bone marrow mean Dr Bobby Gaspar decides the treatment needs to be delayed as the risk is too high. She and her family are disconsolate as they must return home to Scotland and wait to attempt a cure again.

As well as portraying the lives of the families involved, during the documentary we also come to understand the motivations of the staff and why they are willing to take the sort of risks that many other doctors would be unwilling to. Professor Veys says that the thing he always regrets is taking treatment too far and causing too much pain. However, he says, once in a while there is one child who defies the odds and comes through, which spurs them to continue to take chances in the face of adversity.

Although the show highlighted the need for more bone-marrow donors, particularly for people with mixed-raced origins, this point could have been made more strongly. The need to go to USA to get a donor for Keano shows just how difficult it can be to find donors for people of mixed-race origins.

The show is an emotional journey, and you would have to be heartless not feel the pain and anguish the families go through. Although the documentary is essentially a big advert for Great Ormond Street Hospital, after the first 15 minutes you don't mind and are simply in awe of the strength of the patients, families and staff.

I challenge anyone to watch the documentary and not want to support the work of Great Ormond Street.

SOURCES & REFERENCES

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

22 February 2016 - by Julianna Photopoulos 
Trials using genetically engineered immune cells have shown 'extraordinary results' in treating blood cancers in terminally ill patients, say researchers...
14 December 2015 - by Dr James Heather 
Two patients enrolled in a clinical trial of a gene therapy to treat severe congenital immunodeficiency have shown signs of substantial improvement in their condition...

27 April 2015 - by Isobel Steer 
Six boys with the inherited immune disorder Wiskott-Aldrich Syndrome (WAS) have been successfully treated with a gene-therapy technique that harnesses a 'tamed' HIV virus...
13 October 2014 - by Dr James Heather 
Gene therapy to treat children with 'bubble boy syndrome' seems to be both safe and effective, a study published in the New England Journal of Medicine has found...
05 March 2012 - by Ayesha Jadoon 
Early trials in patients with chronic granulomatous disorder (x-CGD), a recessive X-linked condition that affects the immune system, have shown signs of success following the use of gene therapy. The observed boost in immunity of those undergoing treatment was only temporary, however, and the faulty gene causing x-CGD was not corrected permanently....
30 August 2011 - by Rosemary Paxman 
Over a dozen children with 'boy in bubble' syndrome are alive and well, with functioning immune systems, nine years after undergoing gene therapy to correct their disorder, researchers report....
15 November 2010 - by Chris Chatterton 
Doctors from Great Ormond Street Hospital (GOSH) have used stem cells from donated cord blood to treat a child with a rare genetic disorder....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation